InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Invivyd, Inc.

IVVD Clue Score60
United States Fiscal year ends December CIK 0001832038 Results filed 13 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
Kevin F McLaughlin
19 Nov 2025
Director
Buy
50,000
$2.50
$125.00K
David Hering
1 Sep 2022
Chief Executive Officer
Buy
8,000
$4.52
$36.16K
Marc Elia
19 Aug 2022
Director
Buy indirect
584,451
$4.62
$2.70M
Marc Elia
18 Aug 2022
Director
Buy indirect
1,265,549
$4.31
$5.45M
Marc Elia
17 Aug 2022
Director
Buy indirect
1,000,000
$4.04
$4.04M
Redmile Group, LLC
10 Aug 2021
10% owner
Buy indirect
1,470,000
$17.00
$24.99M
Terrance McGuire
10 Aug 2021
Director
Buy indirect
177,500
$17.00
$3.02M
Terrance McGuire
10 Aug 2021
Director
Buy indirect
45,000
$17.00
$765.00K
Terrance McGuire
10 Aug 2021
Director
Buy indirect
2,678
$17.00
$45.53K
Terrance McGuire
10 Aug 2021
Director
Buy indirect
1,834
$17.00
$31.18K
Terrance McGuire
10 Aug 2021
Director
Buy indirect
5,219
$17.00
$88.72K
Terrance McGuire
10 Aug 2021
Director
Buy indirect
267,769
$17.00
$4.55M
Mithril II LP
10 Aug 2021
10% owner
Buy
1,997,000
$17.00
$33.95M
Ajay Royan
10 Aug 2021
Director
Buy indirect
1,997,000
$17.00
$33.95M
Show all 61 transactions →

What was left out

Form 4 filings counted 122
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 30
Sales straight out of an exercise 0
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 83,021,309
History held since 9 Aug 2021